Stoke Therapeutics Inc (STOK) Stock Analysis

Stoke Therapeutics Inc (STOK) is a publicly traded company in the HEALTHCARE sector. It trades at $28.68, carries a market capitalization of $1.90B. This page summarizes the public market data, fundamentals, and frequently asked questions for STOK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Stoke Therapeutics Inc currently has a Bullish sentiment score of 0.30.

About Stoke Therapeutics Inc

Stoke Therapeutics, Inc. is a leading biopharmaceutical company dedicated to pioneering antisense oligonucleotide (ASO) therapies that tackle the underlying causes of severe genetic disorders. Headquartered in Bedford, Massachusetts, Stoke utilizes its proprietary technology platform to design and enhance ASOs, demonstrating a robust commitment to advancing genetic medicine. With its innovative approach and ongoing research and development initiatives, the company is well-positioned to transf...

GNG Research Analysis

GNG Research scores Stoke Therapeutics Inc (STOK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for STOK.

Frequently Asked Questions

Does STOK pay dividends?

Stoke Therapeutics Inc (STOK) does not currently pay a regular dividend.

What is STOK's market cap?

Stoke Therapeutics Inc (STOK) has a market capitalization of $1.90B with a current stock price of $28.68.